Cambridge Bancorp (CATC) 47.0000 $CATC Cambridge Trust

New Post Public Reply Private Reply Replies (0) Message Board

Jul 11, 2015 at 7:43 PM

Cambridge Bancorp (CATC) 47.0000 $CATC

Cambridge Trust Company Announces Plans to Relocate Administrative Offices to Burlington
Business Wire - Tue Jun 09, 11:48AM CDT
Cambridge Trust Company announced plans to relocate their administrative offices to 78 Blanchard Road in Burlington, MA. The move will relocate approximately 100 employees from their current Fresh Pond, Cambridge office.

Cambridge Bancorp declares $0.45 dividend
Seeking Alpha - at Seeking Alpha - Tue May 19, 9:36AM CDT

Cambridge Bancorp Announces Quarterly Dividend
Business Wire - Tue May 19, 8:00AM CDT
Cambridge Bancorp (OTC QB: CATC) announced that its Board of Directors has approved a quarterly dividend of $0.45 per share. The dividend is payable June 30, 2015 to shareholders of record as of June 10, 2015.

Cambridge Bancorp Reports First Quarter Results
Business Wire - Mon Apr 27, 8:00AM CDT
Cambridge Bancorp (OTC QB: CATC) today reported unaudited net income of $3,733,000 for the first quarter of 2015 compared to $3,511,000 for the same quarter in 2014. The earnings increase of $222,000 (6.3%) was attributable to a combination of sustained growth in both net interest income and noninterest income offset by higher noninterest expense for the quarter ended March 31, 2015. Diluted earnings per share were $0.94 for the first quarter of 2015 versus $0.89 for the same period in 2014.

Generating Income From Dividend Growth
Jason Draut - at Seeking Alpha - Thu Mar 26, 12:35PM CDT

BTI: 112.52 (+3.75), PNY: 36.93 (+0.42), XOM: 82.22 (+0.62), OGE: 28.76 (+0.11), PAA: 43.21 (+0.77), AEP: 55.56 (+0.04), SPY: 207.48 (+2.58), VVC: 40.39 (+0.28), AGG: 108.38 (-0.46), MMP: 74.37 (+0.80), ARTNA: 21.64 (+0.11), DGAS: 20.08 (+0.01), KO: 40.39 (+0.47), XEL: 33.55 (+0.22), WR: 36.56 (+0.46), SCG: 53.02 (+0.60), FMBH: 21.97 (+0.02), SO: 43.36 (+0.09), PBCT: 16.15 (+0.10), NEE: 101.64 (+0.46), FCAP: 26.25 (-0.15), MCD: 97.65 (+1.16), PG: 80.95 (+0.29), VZ: 47.00 (+0.74), LNT: 60.09 (+0.50)

Cambridge Trust names Denis K Sheahan as new president and CEO
M2 - Tue Mar 03, 4:58AM CST
Bank holding company Cambridge Bancorp (OTCBB:CATC) and its subsidiary Cambridge Trust Company, on Tuesday named Denis K. Sheahan as the chief executive officer (CEO) elect, from 1 April 2015.

Cambridge Trust Company Appoints Denis K. Sheahan as New President and CEO
Business Wire - Mon Mar 02, 3:10PM CST
Cambridge Bancorp (OTCBB: CATC) and its subsidiary, Cambridge Trust Company, announced that banking veteran Denis K. Sheahan, currently Chief Operating Officer of Independent Bank Corp., parent of Rockland Trust Company, has been appointed the Company's CEO Elect effective April 1, 2015. Sheahan will be formally appointed President, CEO and Board Chairman at Cambridge Bancorp's Directors meeting on April 27, 2015. Sheahan will succeed Joseph V. Roller II, who has served as President and CEO of Cambridge Trust Company since 2002 and who previously announced his intent to retire in mid-2015.

Cambridge Bancorp Increases Quarterly Dividend
Business Wire - Wed Feb 18, 8:02AM CST
Cambridge Bancorp (OTCBB: CATC) announced that its Board of Directors has approved a 7.1 percent increase in its quarterly dividend from $0.42 per share to $0.45 per share. The dividend is payable March 30, 2015 to shareholders of record as of March 10, 2015.

Cambridge Bancorp Announces Record Earnings for Full Year 2014
Business Wire - Tue Jan 27, 8:01AM CST
Cambridge Bancorp (OTCBB: CATC) today announced unaudited net income of $14,944,000 for the year ended December 31, 2014, representing an increase of $804,000, or 5.7%, compared to net income of $14,140,000 for the year ended December 31, 2013. Diluted earnings per share (EPS) were $3.78, a 4.4% increase over diluted earnings per share for the prior year.

'Overdue' Dividend Increases (And Other Streaks At Risk)
David Fish - at Seeking Alpha - Sun Dec 07, 5:01PM CST

ASH: 118.43 (+2.24), SJR: 21.37 (+0.32), CAG: 44.83 (+0.31), UTX: 110.18 (+1.26), PSA: 196.13 (+2.40), BOBE: 51.19 (+0.69), CAE: 11.46 (+0.29), COH: 33.38 (+0.30), FAST: 42.33 (+0.33), MOCO: 16.00 (+0.11), AMAT: 18.77 (+0.25), ORIT: 15.97 (+0.02), CHS: 16.21 (+0.17), MCK: 229.56 (+2.66), PETS: 18.00 (+0.45), UBSI: 41.82 (+0.55), WTI: 4.67 (-0.08), TGH: 24.90 (+0.37), ORCL: 40.36 (+0.18), DRI: 72.16 (+0.60), WABC: 51.79 (+0.76), ESV: 20.39 (-0.59), HCI: 43.91 (+0.99), NAUH: 3.05 (+0.13), CLMT: 27.11 (+0.33), PETM: 82.98 (+0.03)

Dividend Contenders: 26 Increases Expected In The Next 11 Weeks
David Fish - at Seeking Alpha - Mon Nov 17, 6:36AM CST

RGCO: 20.88 (+0.13), ROP: 172.35 (+0.79), SEIC: 49.35 (+0.63), NKE: 110.52 (+1.08), SJI: 25.19 (+0.48), AEL: 26.65 (+0.53), YORW: 22.30 (+0.69), ECL: 112.28 (+1.67), SYK: 96.37 (+0.71), AXS: 56.03 (+0.59), TGP: 31.26 (+0.53), JJSF: 112.14 (+1.68), GGG: 68.89 (+0.12), NWFL: 30.64 (+0.64), CVS: 107.44 (+1.74), UBA: 19.24 (+0.22), ERIE: 84.83 (+1.04), ANDE: 37.94 (+0.34), EIX: 57.95 (+0.37), LG: 53.64 (+0.14), LNT: 60.09 (+0.50), VGR: 23.92 (+0.29)

Update: Cambridge Bancorp Q3 Earnings
Profit Fan - at Seeking Alpha - Sat Nov 01, 4:06AM CDT

Cambridge Bancorp Announces Third Quarter Results
Business Wire - Tue Oct 21, 8:00AM CDT
Cambridge Bancorp (OTCBB: CATC) today reported unaudited net income of $3,926,000 for the third quarter of 2014 compared to $3,695,000 for the same quarter in 2013. Diluted earnings per share (EPS) were $0.99 for the third quarter of 2014 versus $0.94 for the same quarter in 2013. For the nine months ending September 30, 2014, unaudited net income was $11,078,000 versus $10,501,000 for the same period in 2013. Diluted earnings per share were $2.80 for the nine month period versus $2.69 for the same period in 2013.

Dividend Contenders: 34 Increases Expected By December 31
David Fish - at Seeking Alpha - Sat Oct 18, 5:44PM CDT

CASS: 57.60 (+1.73), MATW: 54.24 (+1.78), SEIC: 49.35 (+0.63), SFG: 76.48 (+1.12), NKE: 110.52 (+1.08), NKSH: 30.26 (+0.23), MDU: 19.07 (unch), SJI: 25.19 (+0.48), AEL: 26.65 (+0.53), MSM: 70.30 (-1.13), UMBF: 56.92 (+0.89), AAN: 36.51 (+0.85), YORW: 22.30 (+0.69), SYK: 96.37 (+0.71), ECL: 112.28 (+1.67), AXS: 56.03 (+0.59), WHG: 60.35 (+1.32), JJSF: 112.14 (+1.68), AROW: 27.24 (+0.24), LECO: 60.17 (+0.32), BRO: 33.65 (+0.37), WABC: 51.79 (+0.76), UBA: 19.24 (+0.22), RGLD: 60.84 (-1.11), ANDE: 37.94 (+0.34), UTMD: 59.58 (+0.57), EIX: 57.95 (+0.37), LG: 53.64 (+0.14), PB: 55.73 (+0.61), VGR: 23.92 (+0.29)

Cambridge Bancorp Reports Second Quarter Earnings
Business Wire - Tue Jul 22, 8:01AM CDT
Cambridge Bancorp (OTCBB: CATC) today reported unaudited net income of $3,641,000 for the second quarter of 2014 compared to $3,475,000 for the same quarter in 2013. The increase in earnings of $166,000 (4.8%) was attributable to growth in both net interest income and noninterest income, offset by an increase in noninterest expense. Diluted earnings per share were $0.92 for the second quarter of 2014 compared to $0.89 for the same quarter in 2013. For the six months ended June 30, 2014, unaudited net income was $7,152,000, an increase of $346,000 (5.1%) compared to $6,806,000 for the first half of 2013. Diluted earnings per share were $1.81 for the first six months of 2014 versus $1.75 for the same period in 2013.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...